Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial

Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.5. This indicates a minor update to the page's metadata or formatting.
    Difference
    0.1%
    Check dated 2026-06-06T23:51:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.5.4 indicates a new build of the ClinicalTrials.gov interface. This is a routine release update and does not modify the listed study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-16T10:11:09.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer was updated to a new software/site revision version (from v3.5.2 to v3.5.3). This reflects a site/version update rather than any change to the study record information.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:27.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:35:44.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:06:42.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:49:11.000Z thumbnail image

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.